Qualisure Diagnostics is actively seeking investment to scale, expand our team, and continue product development. Our next funding round is in progress and expected to close by the end of Q2 2023. To participate, or obtain further information, please contact us here.
- Talented, innovated team with diverse expertise and proven leadership capabilities
- We are world class researchers, with deep knowledge of oncology
- Our lead product is the solution to an unmet clinical need. We have developed an asset light, repeatable and highly scalable business model
- We have a big vision! – we are not just a thyroid cancer company. We are a precision oncology company.
- Significant exit potential
- We have launched a validated test that measurably improves patient care for thyroid cancer
- We are at an inflection point, poised for scaling
- Repeatable workflow has been established
- Follow-on products are in advanced development
Investor Information Request
"*" indicates required fields